Business
Fidelity Bank’s Trade Expo gets Mayor of Houston’s endorsement
Fidelity Bank’s upcoming trade expo tagged, the Fidelity International Trade and Creative Connect (FITCC Houston), has received a major boost as the Mayor, City of Houston, Sylvester Turner, has termed it, “A catalyst to support bilateral trade between Nigeria and Houston; and an opportunity for the Houston community and the diaspora to explore emerging trends, forge new partnerships and unlock new possibilities”.
This was made known in a video message recently issued by the mayor. In the one-minute clip obtained by our journalist, the Mayor Turner highlighted the several side attractions scheduled for FITCC Houston and encouraged businesses to take advantage of the expo to expand their businesses beyond borders.
READ ALSO: Parallex Bank spreads tentacles, opens another office on Marina
The event is scheduled for Tuesday, 24 and Wednesday, 25th October 2023 at the George R. Brown Convention Center, 1001 Avenida de las Americas, Houston, Texas 77010.
The bank will be hosting exporters, leading businesses, entrepreneurs, investors and regulators operating in the commodity, service, creative, fashion and FinTech sectors in Nigeria and the United States with the view of promoting Nigeria’s non-oil exports and facilitating integrations to global supply-chain networks.
-
Features7 days agoHow ADC leadership crisis put Atiku’s 2027 ambition at risk
-
Energy7 days agoNNPC plans 5–10% stock market listing, targets 2027 for IPO preparations
-
Business1 week agoLoveWorld Expo 2026 to showcase global innovations, emerging technologies in Lagos
-
Business4 days agoDisCos urge Minister to end blame game, apologise to Nigerians over blackouts
-
Latest1 week ago2027: No Court rulings can keep me off the ballot, Atiku insists
-
Latest1 week agoNDC faults Tinubu’s $7.7bn external loan request, raises debt concerns
-
Latest1 week ago2027: Wike declares Obi’s political wave dead, dismisses chances of presidential victory
-
Health5 days agoStudy links Pfizer COVID-19 vaccine to higher death rates than Moderna shot


